Analyst & Firm	Company	Rating & Price Target	Upside / Downside
Wes GolladayRobert W. Baird	VTR Ventas	BUY$65	11.38% Upside
Derrick WoodTD Cowen	SAP SAP AG	BUY$305	16.60% Upside
Bose GeorgeKBW	RWT Redwood	BUY$8.25	28.30% Upside
David KonradKBW	BAC Bank of America	BUY$57	22.21% Upside

Daily Sell Ratings

Analyst & Firm	Company	Rating & Price Target	Upside / Downside
David KonradKBW	PNC PNC Financial	SELL$215	9.39% Upside
Dan LevyBarclays	PSNY Polestar Automotive Holding UK	SELL$1	-7.83% Downside
Manav PatnaikBarclays	MAN ManpowerGroup	SELL$55	-7.31% Downside
Brandon OglenskiBarclays	EXPD Expeditors International	SELL$110	-1.09% Downside

Full List of Stock Ratings

(Jan 17, 2025)

Analyst Performance

Any

Analyst Rating

Any

Upside / Downside

Any

Action

Any

Market Cap

Any

Analyst & Firm	Company	Rating & Price Target	Upside / Downside	Average Return	Action	Date	Article
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	HOLD $170	―	4.10%	Reiterated	2025-01-17
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	BUY $58	―	13.50%	Assigned	2025-01-17
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	HOLD $235	―	13.50%	Reiterated	2025-01-17
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	BUY $156	―	13.50%	Reiterated	2025-01-17
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	BUY $257	―	13.50%	Reiterated	2025-01-17
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	BUY $61	―	13.50%	Assigned	2025-01-17
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	HOLD $76	―	15.20%	Assigned	2025-01-17
Christine Cho CFABarclays	SHLS Shoals Technologies Group	HOLD $4	―	-1.00%	Reiterated	2025-01-17	Barclays Sticks to Their Hold Rating for Shoals Technologies Group (SHLS)
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	BUY $92	―	19.90%	Assigned	2025-01-17
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	BUY $14	―	13.20%	Upgraded	2025-01-17
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	SELL $8	―	13.20%	Assigned	2025-01-17
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	BUY $225	―	11.50%	Upgraded	2025-01-17
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	BUY $95	―	11.50%	Upgraded	2025-01-17
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	BUY $66	―	11.80%	Reiterated	2025-01-17
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	BUY $80	―	23.10%	Reiterated	2025-01-17
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	HOLD $22→$22.5	―	2.30%	Downgraded	2025-01-17
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	BUY $145	―	5.70%	Assigned	2025-01-17
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	BUY $255	―	0.40%	Reiterated	2025-01-17
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	SELL $85→$90	―	1.70%	Reiterated	2025-01-17
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	SELL $139→$130	―	1.70%	Reiterated	2025-01-17
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	BUY $86→$83	―	1.70%	Reiterated	2025-01-17
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	HOLD $96→$83	―	1.70%	Reiterated	2025-01-17
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	SELL $7→$6	―	1.70%	Reiterated	2025-01-17
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	HOLD $36→$33	―	1.70%	Reiterated	2025-01-17
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	HOLD $8→$6	―	4.10%	Reiterated	2025-01-17
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	HOLD $90→$88	―	1.70%	Reiterated	2025-01-17
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	HOLD $23→$21	―	1.70%	Reiterated	2025-01-17
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	BUY $39→$36	―	1.70%	Reiterated	2025-01-17
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	HOLD $144→$132	―	1.70%	Reiterated	2025-01-17
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	SELL $51→$48	―	1.70%	Reiterated	2025-01-17
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	BUY $10→$11	―	1.70%	Reiterated	2025-01-17
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	BUY $21→$19	―	4.10%	Reiterated	2025-01-17
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	HOLD $163→$155	―	1.70%	Reiterated	2025-01-17
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	HOLD $28→$27	―	1.70%	Reiterated	2025-01-17
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	BUY $73→$66	―	1.70%	Reiterated	2025-01-17
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	HOLD $86→$71	―	1.70%	Reiterated	2025-01-17
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	HOLD $32→$35	―	4.10%	Reiterated	2025-01-17
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	BUY $19→$17	―	4.10%	Reiterated	2025-01-17
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	SELL $19→$16	―	4.10%	Reiterated	2025-01-17
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	BUY $160	―	10.50%	Reiterated	2025-01-17
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	BUY $69	―	4.10%	Reiterated	2025-01-17
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	HOLD $33	―	4.10%	Reiterated	2025-01-17
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	BUY $158	―	1.70%	Reiterated	2025-01-17
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	HOLD $181.25	―	1.40%	Reiterated	2025-01-17
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	BUY $4.5→$3	―	5.80%	Reiterated	2025-01-17
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	BUY $115→$150	―	13.50%	Reiterated	2025-01-17
Peter LawsonBarclays	RLAY Relay Therapeutics	BUY $17	―	-3.70%	Assigned	2025-01-17	Relay Therapeutics (RLAY) Gets a Buy from Barclays
Betty JiangBarclays	COP Conocophillips	BUY $137	―	-0.20%	Reiterated	2025-01-17
Jared ShawBarclays	FHN First Horizon	BUY $25	―	-0.40%	Reiterated	2025-01-17	Barclays Sticks to Its Buy Rating for First Horizon (FHN)
xxxxxxxxxxxxxxxxxx	xxxxxxxxxxxxxxxxxxxxxxxxxxx	SELL $77	―	10.00%	Reiterated	2025-01-17

Rows:

Ready for the Full Picture?Your current plan limits your access to top-tier analyst ratings. Subscribe to Premium now and unlock the full range of ratings from the highest-ranked analysts on Wall Street. Don't let partial views limit your market research potential - upgrade today!

Upgrade Now Plans & Pricing